| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9822 | 
      | Human Intestinal Absorption | HIA+ | 0.9456 | 
      | Caco-2 Permeability | Caco2+ | 0.7066 | 
      | P-glycoprotein Substrate | Non-substrate | 0.8959 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9793 | 
                                                     | Non-inhibitor | 0.9814 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9269 | 
        
            | Distribution | 
        
      | Subcellular localization | Lysosome | 0.4936 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8433 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.7451 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.7941 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.7925 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.8935 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9444 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9194 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9627 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9250 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9658 | 
                                                                    | Non-inhibitor | 0.9549 | 
      | AMES Toxicity | Non AMES toxic | 0.8722 | 
      | Carcinogens | Carcinogens  | 0.7363 | 
      | Fish Toxicity | Low FHMT | 0.5779 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.6557 | 
      | Honey Bee Toxicity | High HBT | 0.8111 | 
      | Biodegradation | Not ready biodegradable | 0.5851 | 
      | Acute Oral Toxicity | III | 0.6819 | 
      | Carcinogenicity (Three-class) | Non-required | 0.4669 |